| _version_ |
1797287142162956288
|
| collection |
DOAJ
|
| first_indexed |
2024-03-07T18:28:40Z
|
| format |
Article
|
| id |
doaj.art-114d763e334348598c99e78aa52aaa74
|
| institution |
Directory Open Access Journal
|
| issn |
2572-9241
|
| language |
English
|
| last_indexed |
2024-03-07T18:28:40Z
|
| publishDate |
2018-10-01
|
| publisher |
Wiley
|
| record_format |
Article
|
| series |
HemaSphere
|
| spelling |
doaj.art-114d763e334348598c99e78aa52aaa742024-03-02T06:41:26ZengWileyHemaSphere2572-92412018-10-0124810.1097/01.HS9.0000547964.15415.bd201810003-00121P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANThttp://journals.lww.com/10.1097/01.HS9.0000547964.15415.bd
|
| spellingShingle |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
HemaSphere
|
| title |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
|
| title_full |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
|
| title_fullStr |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
|
| title_full_unstemmed |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
|
| title_short |
P120 (0086) OUTCOMES AND TOXICITIES AFTER BRENTUXIMAB VEDOTIN (BV) MAINTENANCE IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENT EXPOSED TO BV PRIOR TO AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT
|
| title_sort |
p120 0086 outcomes and toxicities after brentuximab vedotin bv maintenance in relapsed refractory hodgkin lymphoma patient exposed to bv prior to autologous hematopoietic stem cell transplant
|
| url |
http://journals.lww.com/10.1097/01.HS9.0000547964.15415.bd
|